BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 14, 2010
View Archived Issues
Encouraging phase I data disclosed on phIL-12-005/PPC in recurrent ovarian cancer
Read More
Novartis claims new inhibitors of SGLT-1 and SGLT-2
Read More
Roche presents new dual 5-HT2A and dopamine D3 receptors modulators
Read More
Karo Bio identifies novel estrogen receptor beta ligands
Read More
Merck Frosst claims new prostanoid DP2 receptor antagonists
Read More
Swedish scientists claim new SSAO inhibitors
Read More
ChemoCentryx identifies new CMKLR1 receptor antagonist
Read More
Preliminary data disclosed from long-term safety/efficacy phase III trial of LibiGel in HSDD
Read More
Almirall presents new DHODH inhibitors suitable for clinical development
Read More
Bazedoxifene shows potential as endometriosis therapy in preclinical study
Read More
Clinical data disclosed on avosentan in overt diabetic nephropathy
Read More
Janssen-Ortho discontinues sale of ceftobiprole in Canada
Read More
Clinical data disclosed on lamotrigine in secondary progressive multiple sclerosis
Read More
Teva's Copaxone reaches one million patient years of experience in multiple sclerosis
Read More
Affinium begins phase I trial of new antistaphylococcal antibiotic AFN-1252
Read More
Medinox and Orient Europharma partner for antihypotensive drug NOX-100
Read More
Alkermes submits Vivitrol sNDA in U.S. for opioid dependence
Read More
Israeli government awards grant to Prolor Biotech for longer-acting human growth hormone
Read More
PharmaSurgics' phase II PXL-01 trial extended to Denmark
Read More
Arecor and Genzyme join to develop advanced therapeutic protein formulations
Read More
RXi and Mirna Therapeutics form microRNA research collaboration
Read More
FDA approves Sinapis' methamphetamine IND for stroke
Read More
Sanofi Pasteur and U.S. Naval Medicine Center partner to develop travelers' diarrhea vaccine
Read More
FDA approves Johnson & Johnson's Pancreaze delayed-release capsules
Read More
Aushon launches multiplex biomarker panels to aid measurement of vascular injury
Read More